Clinical Trial Update: Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of pramlintide in individuals with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• pramlintide (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED